normal pressure hydrocephalus

normal pressure hydrocephalus
Name	Normal pressure hydrocephalus
Field	Neurology, Neurosurgery

normal pressure hydrocephalus. It is a neurological condition characterized by a triad of gait disturbance, cognitive impairment, and urinary incontinence, occurring alongside enlarged cerebral ventricles but with cerebrospinal fluid pressure within the normal range. First described in 1965 by Salomón Hakim and Raymond D. Adams, it represents a potentially treatable cause of dementia and mobility issues, often requiring differentiation from other neurodegenerative disorders like Alzheimer's disease and Parkinson's disease.

Signs and symptoms

The classic clinical presentation, known as **Hakim's triad**, includes gait apraxia, cognitive decline, and urinary urgency or incontinence. Gait disturbance is often the most prominent and earliest sign, manifesting as a magnetic, shuffling walk with difficulty initiating steps, which can resemble the gait seen in Parkinson's disease. Cognitive symptoms typically involve a subcortical dementia pattern with slowing of thought processes, apathy, and executive dysfunction, distinct from the memory-predominant deficits of Alzheimer's disease. Urinary symptoms usually appear later and range from frequency and urgency to complete incontinence. Patients may also report other neurological symptoms such as vertigo or syncope, and the condition can sometimes be misdiagnosed as other disorders like vascular dementia or progressive supranuclear palsy.

Causes and pathophysiology

The exact etiology often remains idiopathic, but it can be secondary to events that impair cerebrospinal fluid absorption or flow, such as subarachnoid hemorrhage, meningitis, traumatic brain injury, or previous cranial surgery. The pathophysiological model, proposed by Salomón Hakim, suggests an imbalance between CSF production and absorption leads to ventricular enlargement, stretching periventricular white matter tracts like the corona radiata and corticospinal tract. This mechanical distortion is thought to disrupt frontal lobe circuits and deep brain structures, including connections to the basal ganglia and thalamus, leading to the characteristic symptoms. Research institutions like the National Institutes of Health and the Mayo Clinic continue to investigate underlying mechanisms, including possible links to cerebral small vessel disease.

Diagnosis

Diagnosis is primarily clinical but requires neuroimaging confirmation. Computed tomography or Magnetic resonance imaging of the brain demonstrates ventriculomegaly disproportionate to any cortical atrophy, often with features like periventricular white matter changes. The Evans' index, a linear measurement ratio, is a common radiographic criterion. To support the diagnosis and predict surgical response, ancillary tests are used. These include a high-volume **lumbar puncture** or **extended lumbar drainage** (a temporary procedure often conducted in a hospital setting like Johns Hopkins Hospital) to assess for clinical improvement. More specialized tests include **infusion tests** to measure CSF outflow resistance and **cerebrospinal fluid dynamics** studies. Differential diagnosis is crucial to rule out conditions such as Alzheimer's disease, Lewy body dementia, and cervical spondylotic myelopathy.

Treatment

The primary and definitive treatment is the surgical implantation of a **cerebrospinal fluid shunt**, which diverts excess fluid from the cerebral ventricles to another body cavity, most commonly the peritoneal cavity (a **ventriculoperitoneal shunt**). Alternative drainage sites include the right atrium of the heart (a **ventriculoatrial shunt**). The procedure is performed by a neurosurgeon and involves placing a catheter connected to a valve system that regulates flow. Programmable valves, which allow non-invasive pressure adjustment, are now commonly used. A less common alternative is **endoscopic third ventriculostomy**, which creates a new pathway for CSF flow within the ventricular system. Post-operative management often involves teams at major neurosurgical centers like the Cleveland Clinic or Massachusetts General Hospital to monitor for complications such as subdural hematoma or shunt infection.

Prognosis

Prognosis is highly variable and depends on early diagnosis, the underlying cause, and the patient's response to shunting. Gait symptoms often show the most dramatic and rapid improvement following successful shunt surgery. Cognitive symptoms may improve but often incompletely, and long-standing deficits may be irreversible. Urinary control frequently improves as well. Without treatment, the condition typically progresses, leading to severe disability, increased risk of falls and related injuries, and eventual need for full-time care. Outcomes are systematically tracked by organizations like the International Society for Hydrocephalus and Cerebrospinal Fluid Disorders.

Epidemiology

Normal pressure hydrocephalus is considered an underdiagnosed condition. Its prevalence increases with age, most commonly affecting adults over 60 years old. Estimated prevalence in the elderly population ranges widely, with some studies suggesting it may account for up to 5-6% of all dementia cases. There is no well-established gender predilection, and most cases are sporadic. Large-scale epidemiological data has been contributed by studies from the Framingham Heart Study and the Rotterdam Study. Given the aging global population, awareness campaigns by bodies like the World Health Organization and advocacy groups emphasize its importance as a reversible neurological syndrome.

Category:Neurological disorders Category:Hydrocephalus Category:Geriatrics